Gastroenterology

Gastroenterology

Volume 108, Issue 2, February 1995, Pages 428-433
Gastroenterology

Antineutrophil antibodies in familial inflammatory bowel disease

https://doi.org/10.1016/0016-5085(95)90070-5Get rights and content

Abstract

Background/Aims: Antineutrophil cytoplasmic antibodies have been reported to occur more frequently in healthy first-degree relatives of patients with ulcerative colitis than in healthy controls. The aim of this study was to determine their prevalence in families in which more than one member was affected with inflammatory bowel disease. Methods: With use of an indirect immunofluorescence method, 168 affected members and 197 unaffected first-degree relatives in 56 such families were studied. Results: Antibodies were detected in 46% of patients with ulcerative colitis without a positive family history and in 44% of those within families with several affected members. There was no evidence of clustering of antibodies in particular families. Within families in which both ulcerative colitis and Crohn's disease coexisted, antibodies were detected primarily in patients with ulcerative colitis. Antibodies were seldom present (3%) in those patients with Crohn's disease, whether they were familial or nonfamilial cases. Similarly, antibodies were seldom present (3%) in controls or the unaffected first-degree relatives of patients with inflammatory bowel disease. Conclusions: Antineutrophil cytoplasmic antibodies are associated with ulcerative colitis, and their presence is not increased in the first-degree relatives of patients with ulcerative colitis. They are more likely to be a consequence of the disease than a subclinical genetic disease marker.

References (24)

  • G Cambridge et al.

    Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role

    Gut

    (1992)
  • E Romas et al.

    Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease

    Aust NZ J Med

    (1992)
  • Cited by (70)

    • Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives

      2013, Digestive and Liver Disease
      Citation Excerpt :

      Abnormal intestinal permeability has been found in unaffected relatives of patients with Crohn's disease [9–13] and increased levels of faecal calprotectin, a marker of subclinical inflammation, has also been reported in relatives of patients with either Crohn's disease or ulcerative colitis [14,15]. p-ANCA prevalence in unaffected first-degree relatives of ulcerative colitis patients is not uniform among studies, but it is almost similar to the general population [16–19], whereas ASCA are more expressed in unaffected first-degree relatives of Crohn's disease patients than in the general population, with a prevalence of 20–25% [20,21]. Mei et al. [22] also reported an increased prevalence of anti-OmpC in unaffected family members compared to healthy controls (15.5–18.7% vs 6%).

    • Inflammatory Bowel Disease

      2013, Emery and Rimoin's Principles and Practice of Medical Genetics
    • Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease

      2009, Gastroenterology Clinics of North America
      Citation Excerpt :

      Some authors have reported that 16% to 30% of healthy first-degree relatives of patients with UC are positive for atypical p-ANCA.45,46 However, other authors were not able to confirm this finding.47,48 Among patients with Crohn disease, it has been consistently shown that 20% to 25% of healthy first-degree family members are ASCA positive.14–16

    • (Auto)Antibodies in Inflammatory Bowel Diseases

      2008, Gastroenterology Clinics of North America
    View all citing articles on Scopus

    Supported by the Crohn's in Childhood Research Association and the Middlesex Hospital Research and Development Fund.

    View full text